BEAM vs COAG: stock comparison and AI forecast
Beam Therapeutics Inc. (BEAM) and Hemab Therapeutics Holdings, Inc. (COAG) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BEAM Beam Therapeutics Inc.
- Market Cap
- $2.67B
- P/E Ratio
- 369.6x
- Size
- mid-cap
- AI Forecast
COAG Hemab Therapeutics Holdings, Inc.
- Price
- $45.57 +73.3% · 6M
- Market Cap
- $2.13B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BEAM is 1.3 times larger than COAG by market capitalization ($2.67B against $2.13B).
- BEAM carries 0.33 times debt per unit of equity, against 0.03 times for COAG.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BEAM | COAG |
|---|---|---|
| Market Cap | $2.67B | $2.13B |
| P/E Ratio | 369.56x | – |
| P/B Ratio | 2.80x | 4.69x |
| EPS | $0.07 | – |
| Book Value/Share | $9.22 | $9.72 |
| Revenue/Share | $1.42 | – |
| FCF/Share | $-3.86 | – |
Profitability & Margins
| Metric | BEAM | COAG |
|---|---|---|
| ROIC | -33.1% | – |
| Operating Margin | -267.7% | – |
| EBT Margin | -89.2% | – |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | BEAM | COAG |
|---|---|---|
| Current Ratio | 13.00x | 35.85x |
| D/E Ratio | 0.33x | 0.03x |
| Financial Leverage | 1.33x | 1.03x |
| Interest Coverage | -54.5x | – |
| Working Capital | $985M | $451M |
Cash Flow
| Metric | BEAM | COAG |
|---|---|---|
| Operating Cash Flow | -$389M | – |
| Free Cash Flow | -$398M | – |
| Capital Spending | -$10M | – |
| FCF/Sales | -271.6% | – |
| CapEx/Sales | 6.5% | – |
Operational Efficiency
| Metric | BEAM | COAG |
|---|---|---|
| Asset Turnover | 0.12x | – |
| Fixed Assets Turnover | 1.6x | – |
Income Statement
| Metric | BEAM | COAG |
|---|---|---|
| Total Revenue | $147M | – |
| Operating Income | -$393M | – |
| R&D Expense | $409M | – |
Dividend & Shareholder Information
| Metric | BEAM | COAG |
|---|---|---|
| Shares Outstanding | 103M | 47M |
BEAM vs COAG: stock comparison and AI forecast
Which is bigger, BEAM or COAG?
BEAM is 1.3 times larger than COAG by market capitalization ($2.67B against $2.13B).
Which one does Intratio's AI model rank higher, BEAM or COAG?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.